David Nemazee
David Nemazee
Verified email at scripps.edu
Title
Cited by
Cited by
Year
Receptor editing in self-reactive bone marrow B cells.
SL Tiegs, DM Russell, D Nemazee
The Journal of experimental medicine 177 (4), 1009-1020, 1993
12021993
Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes
DA Nemazee, K Bürki
Nature 337 (6207), 562-566, 1989
11541989
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling
AL Gavin, K Hoebe, B Duong, T Ota, C Martin, B Beutler, D Nemazee
Science 314 (5807), 1936-1938, 2006
6252006
Rational HIV immunogen design to target specific germline B cell receptors
J Jardine, JP Julien, S Menis, T Ota, O Kalyuzhniy, A McGuire, D Sok, ...
Science 340 (6133), 711-716, 2013
5352013
Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice.
E Spanopoulou, CA Roman, LM Corcoran, MS Schlissel, DP Silver, ...
Genes & Development 8 (9), 1030-1042, 1994
4701994
The immune epitope database and analysis resource: from vision to blueprint
B Peters, J Sidney, P Bourne, HH Bui, S Buus, G Doh, W Fleri, ...
PLoS biol 3 (3), e91, 2005
4412005
Receptor editing in lymphocyte development and central tolerance
D Nemazee
Nature Reviews Immunology 6 (10), 728-740, 2006
4362006
Peripheral deletion of self-reactive B cells
DM Russell, Z Dembić, G Morahan, J Miller, K Bürki, D Nemazee
Nature 354 (6351), 308-311, 1991
4181991
Contribution of receptor editing to the antibody repertoire
R Casellas, TAY Shih, M Kleinewietfeld, J Rakonjac, D Nemazee, ...
science 291 (5508), 1541-1544, 2001
3812001
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
TF Rogers, F Zhao, D Huang, N Beutler, A Burns, W He, O Limbo, C Smith, ...
Science 369 (6506), 956-963, 2020
3382020
Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification
R Pelanda, S Schwers, E Sonoda, RM Torres, D Nemazee, K Rajewsky
Immunity 7 (6), 765-775, 1997
3091997
V (D) J recombination in mature B cells: a mechanism for altering antibody responses
F Papavasiliou, R Casellas, H Suh, XF Qin, E Besmer, R Pelanda, ...
Science 278 (5336), 298-301, 1997
3021997
Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras
D Nemazee, K Buerki
Proceedings of the National Academy of Sciences 86 (20), 8039-8043, 1989
3021989
Revising B cell receptors
D Nemazee, M Weigert
The Journal of experimental medicine 191 (11), 1813-1818, 2000
2982000
Receptor selection in B and T lymphocytes
D Nemazee
Annual review of immunology 18 (1), 19-51, 2000
2832000
Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection
D Melamed, RJ Benschop, JC Cambier, D Nemazee
Cell 92 (2), 173-182, 1998
2731998
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
JG Jardine, T Ota, D Sok, M Pauthner, DW Kulp, O Kalyuzhniy, PD Skog, ...
Science 349 (6244), 156-161, 2015
2702015
Receptor editing occurs frequently during normal B cell development
MW Retter, D Nemazee
The Journal of experimental medicine 188 (7), 1231-1238, 1998
2461998
Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells.
MJ Shlomchik, DA Nemazee, VL Sato, J Van Snick, DA Carson, ...
The Journal of experimental medicine 164 (2), 407-427, 1986
225*1986
BCR ligation induces receptor editing in IgM+ IgD− bone marrow B cells in vitro
M Hertz, D Nemazee
Immunity 6 (4), 429-436, 1997
2091997
The system can't perform the operation now. Try again later.
Articles 1–20